CS202637B1 - Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes - Google Patents

Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes Download PDF

Info

Publication number
CS202637B1
CS202637B1 CS575479A CS575479A CS202637B1 CS 202637 B1 CS202637 B1 CS 202637B1 CS 575479 A CS575479 A CS 575479A CS 575479 A CS575479 A CS 575479A CS 202637 B1 CS202637 B1 CS 202637B1
Authority
CS
Czechoslovakia
Prior art keywords
furyl
nitro
oxadiazolyl
substituted
phenyl
Prior art date
Application number
CS575479A
Other languages
Czech (cs)
Inventor
Frantisek Povazanec
Jaroslav Kovac
Original Assignee
Frantisek Povazanec
Jaroslav Kovac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frantisek Povazanec, Jaroslav Kovac filed Critical Frantisek Povazanec
Priority to CS575479A priority Critical patent/CS202637B1/en
Publication of CS202637B1 publication Critical patent/CS202637B1/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

ČESKOSLOVENSKÁSOCIALISTICKÁREPUBLIKA(19 )CZECHOSLOVAKIASOCIALISTREPUBLIC (19)

POPIS VYNÁLEZUDESCRIPTION OF THE INVENTION

K AUTORSKÉMU OSVEDČENIU 202 637 »« <B1)TO CERTIFICATE 202 637 »« <B1)

W) (23) Výstavná priorita . (22) Přihlášené 24 08 79(21) PV 5754-79 (51) Int. Cl. C 07 D 413/06W) (23) Exhibition priority. (22) Entries 24 08 79 (21) PV 5754-79 (51) Int. Cl. C 07 D 413/06

ÚŘAD PRO VYNÁLEZYOFFICE OFFICE

A OBJEVY (40) Zverejnené 30 04 80(45) Vydané 01 06 83 (75)AND DISCOVERIES (40) Published 30 04 80 (45) Published 01 06 83 (75)

Autor vynálezu POVAŽANEC FRANTIŠEK ing. CSc.Author of the Invention POVAŽANEC FRANTIŠEK ing. CSc.

KOVÁČ JAROSLAV prof. ing. DrSc., BRATISLAVA (54) Sposob přípravy l-/5-nitro-2-furyl/-2-/5-substituovaných-l,3,4-oxadiazolyl/eténov 1KOVÁČ JAROSLAV prof. DrSc., BRATISLAVA (54) Preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethene 1

Vynález rieši nový sposob přípravy l-/5-nitro-2-furyl/-2-/5-sub8tituovaných-l,3»4--oxadiazolyl/eténov. Příprava l-/5-nitro-2-furyl/-2-/5-substituovaných-l,3»4-oxadiazolyl/eténov bole do-posiaí popísaná Sugiharom a Itom (Yakugaku Zasshi 85. 744 /1965/; Chem. Abstr. 63. 13240e/1965/), ktorí ich připravili cyklizáciou Ν,Ν'-disubstituovaných hydrazidov kyselin pou-žitím POClj ako dehydratačného činidla. Nevýhodou tejto metody sú dlhé reakčné Sasy. íalSia metoda, ktorá bola použitá na přípravu tejto skupiny látok, je oxidácia N--substituovaných arylidénhydrazidov kyseliny 3-/5-nitro-2-furyl/akrylovej tetraacetátomolova (Sasaki T., Yoshioka T.: Bull. Chem. Soo. Japan 42» 2989 /1970/). ModifikovanáHuisgenovu metodu použili Sugihara a Ito v japonskom patente (Fujisawa Pharmaceutical Co.Ltd. Japan 17586 /'65/; Chem. Abstr. £2, 18105a /1965/)» keň posobili na 5-substituovanétetrazoly chloridom kyseliny 3-/5-nitrofuryl/akrylovej v xyléne a získali odpovedajúce1,3,4-oxadiazoly. Hlavnou nevýhodou oboch metod sú nízké výtažky a nízká čistota produk-tov.The present invention provides a novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethenes. Preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethene bole ethanes described by Sugihar and Itom (Yakugaku Zasshi 85, 744 (1965); Chem. Abstr) 63, 13240e (1965)) by cyclizing the cykl, Ν-disubstituted acid hydrazides using POCl 2 as a dehydrating agent. The disadvantage of this method is the long reaction Saxons. Another method used to prepare this group of compounds is the oxidation of N-substituted arylidenehydrazides of 3- (5-nitro-2-furyl / acrylic tetraacetate) (Sasaki T., Yoshioka T.: Bull. Chem. Soo. Japan 42 »2989 (1970)]. The modified Huisgen method was used by Sugihara and Ito in Japanese Patent (Fujisawa Pharmaceutical Co.Ltd. Japan 17586 ('65); Chem. Abstr. 2, 18105a / 1965), where they were placed on 5-substituted tetrazoles with 3- / 5-nitrofuryl chloride. acrylic in xylene and obtain the corresponding 1,3,4-oxadiazoles. The main disadvantage of both methods is the low yields and low product purity.

Tieto nevýhody doterajěích postupov odstraňuje nový sposob přípravy l-/5-nitro-2--furyl/-2-/5-substituovaných-l,3,4-oxadiazolyl/eténov, ktořý skracuje reakčné časy zo4 až 1 hodiny na 15 až 20 minút a súčasne poskytuje produkty vo vysokých výtažkoch. 202 637 202 037These disadvantages of the prior art are eliminated by the novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethenes which shortens the reaction times from 4 to 1 hour to 15-20. minutes while providing products in high yields. 202 637 202 037

Syntetizované derivéty sú zaujímavé z hlediska baktericídneho a fungicídneho účinku(A. Sugihara, H. Ito: Yakugaku Zasshi 8J, 744 /1965/; Chám. Abstr. £2, 13240e /1965/)a taktiež štruktúrne patria do tej istej skupiny látok ako Furamizol, ktorý bol zavedenýako liečivo do praxe v roku 1971.Synthesized derivatives are of interest for bactericidal and fungicidal activity (A. Sugihara, H. Ito: Yakugaku Zasshi 8J, 744/1965) and also structurally belong to the same class of substances as Furamizole, which was introduced as a drug in practice in 1971.

Podstata nového sposobu přípravy l-/5-nitro-2-furyl/-2-/5-substituovanýeh-l,3,4-oxa-diazolyl/eténov podlá vynálezu spodíva v tom, že l-/5-nitro-2-furyl/-2-/5-substituované--1,3,4-oxadiazolyl/etény obecného vzorce NOj-iAccording to the invention, the novel process for the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethanes is that 1- (5-nitro-2- furyl (2- [5-substituted-1,3,4-oxadiazolyl] ethenes of general formula (NO-1)

-OH =CH kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-chlór-fenyl/-2-furyl, 5-/2-chlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, sa pripravujú reakciou 5-substituovaných tetrazolov obecného vzorca-OH = CH where R is phenyl, 2-furyl, 5- (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-chlorophenyl) -2-furyl 5- (2-chlorophenyl) -2-furyl and 5- (4-methoxyphenyl) -2-furyl are prepared by reacting 5-substituted tetrazoles of the formula

NH NNH N

R _CZ'"" a H-/ I^H kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-chlór-fenyl/-2-furyl, 5-/2-ehlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, s 3-/5-nitro-2-furyl/akryloylacetylanhydridom vzorcaAnd H- (1 H) wherein R is phenyl, 2-furyl, 5- (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-) chloro-phenyl / -2-furyl, 5- (2-chlorophenyl) -2-furyl and 5- (4-methoxyphenyl) -2-furyl, with 3- (5-nitro-2-furyl) acryloylacetylanhydride of formula

v inertných rozpúštadlách, ako například benzénu, toluénu, o-, m-, p-xylénu, mezitylénu,pri teplotách od 70 do 140 °C. Získané substituované etylény sú vo formě čistých E izomé-rov. Výhoda sposobu podlá vynálezu spočívá okrem iného v tom, že umožňuje přípravu 1-/5--nitro-2-furyl/-2-/5-súbstituovaných-l,3,4-oxadiazolyl/eténov jednoduchým spoeobom v prie-behu 15 až 20 minút, v jednoduchosti izolácie z reakčných zmesí, vysokých výlažkoch a stá-losti a dostupnosti východzích substrátov.in inert solvents such as benzene, toluene, o-, m-, p-xylene, mesitylene, at temperatures from 70 to 140 ° C. The substituted ethylenes obtained are in the form of pure E isomers. The advantage of the process according to the invention is, inter alia, that it allows the preparation of 1- (5-nitro-2-furyl) -2- (5-substituted-1,3,4-oxadiazolyl) ethers by a simple coupling in the course of 15 to 20 minutes, in the simplicity of isolation from the reaction mixtures, the high yields and the stability and availability of the starting substrates.

Predmet vynálezu ilustrujú, ale neobmedzujú, nasledujúce příklady. Příklad 1 Příprava l-/5-nitro-2-furyl/-2-/5-fenyl-l,3,4-oxadiazolyl/eténuThe following examples illustrate, but are not limited to, the following. Example 1 Preparation of 1- (5-nitro-2-furyl) -2- (5-phenyl-1,3,4-oxadiazolyl) ethene

Zmes 1,46 g (0,01 molu) 5-fenyltetrazolu, 1,25 g (0,01 molu) 3-/5-nitro-2-furyl/-akryloylacetylanhydridu a 30 ml xylénu sa zahrieva 15 minút pri teplote 138 °C. Po ochlad-nutí reakčnej zmesi vypadnutý oxadiazol sa odsaje, přeny je etanolom a vysuSÍ. Získá sa 202 637 1,81 g (64 %) E izoméru l-/5-nitro-2-furyl/-2-/5-fenyl-l,3,4-oxadiazolyl/eténu, ktorý pokryštalizécii z etanolu mé t. t. 235 °C. Příklad 2A mixture of 1.46 g (0.01 mol) of 5-phenyltetrazole, 1.25 g (0.01 mol) of 3- (5-nitro-2-furyl) acryloylacetylanic anhydride and 30 ml of xylene was heated at 138 ° C for 15 minutes. C. After cooling the reaction mixture, the precipitated oxadiazole is filtered off with suction, washed with ethanol and dried. 202 637 1.81 g (64%) of the E isomer of 1- (5-nitro-2-furyl) -2- (5-phenyl-1,3,4-oxadiazolyl) ethene were obtained which crystallized from ethanol of m.p. ° C. Example 2

Zmes 1,36 g (0,01 molu) 5-/2-furyl/tetrazolu, 1,25 g (0,01 molu) 3-/5-nitro-2-furyl/akryloylacetylanhydridu V 30 ml toluénu sa zahrieva při teplote 100 °C 20 minút. Po ochladění reakšnej zmeai sa tuhý zvyšok odsaje. Po kryštalizécii surového oxadiazolu z etanoluzíská sa 1,36 g (50 %) l-/5-nitro-2-furyl/-2-/5-/2-furyl/-l,3,4-oxadiazolyl/eténu s t. t.206 až 208 °C. Příklad 3A mixture of 1.36 g (0.01 mol) of 5- [2-furyl / tetrazole, 1.25 g (0.01 mol) of 3- (5-nitro-2-furyl / acryloylacetylanic anhydride) in 30 ml of toluene is heated at 100 ° C for 20 minutes. After cooling the reaction mixture, the solid residue is filtered off with suction. After crystallization of the crude oxadiazole from ethanol, 1.36 g (50%) of 1- (5-nitro-2-furyl) -2- [5- (2-furyl) -1,3,4-oxadiazolyl] ethene with tt206 to 208 ° C. Example 3

Zmes 2,42 g (0,01 molu) 5- 5-/4-metoxyfenyl/-2-furyl tetrazolu, 1,25 g (0,01 molu)3-/5-nitro-2-furyl/akryloylacetylanhydridu v 30 ml benzénu sa zahrieva pošas 20 minút priteplote 80 °C. Po ochladení reakšnej zmesi tuhý zvyšok sa odsaje, premyje etanolom a kryštalizuje z monometyléteru etylénglykolu. Získá sa 2,46 g (65 %) l-/5-nitro-2-furyl/-2-/5-/5-/4-metoxyfenyl/-2-furyl/-l,3,4-oxadiazolyl/eténu s t. t. 234 až 235 °C.A mixture of 2.52 g (0.01 mole) of 5- 5- (4-methoxyphenyl) -2-furyl tetrazole, 1.25 g (0.01 mole) of 3- (5-nitro-2-furyl / acryloylacetylanic anhydride in 30) ml of benzene was heated at 80 ° C for 20 minutes. After cooling the reaction mixture, the solid residue is filtered off with suction, washed with ethanol and crystallized from ethylene glycol monomethyl ether. 2.46 g (65%) of 1- (5-nitro-2-furyl) -2- [5- (4-methoxyphenyl) -2-furyl] -1,3,4-oxadiazolyl / ethene are obtained mp 234-235 ° C.

Tabuíka 1Table 1

Fyzikálně konštanty l-/5-nitro-2-furyl/-2- ^-/5-X-2-furyl/-l,3,4-oxadiazolyl] eténov X Sumérny vzorec Molekulová hmotnost T. t. °C Výtažok % Vy počítané/s tanovené # C % H % N 2-K02CfiH4 394,30 230 až 231 55,05 2,55 14,21 C18H10N4°7 75 54,93 2,54 14,11 4-BrC6H4a 428,21 225 až 226 50,60 2,36 9,83 C18H10BrN3°5 72 50,38 2,44 9,71 3-ClC6H4b 383,75 234 až 235 56,55 2,63 10,95 C18H10C1N3°5 68 56,68 2,71 10,63 2-C1C6h4° 383,75 212 až 213 .56,55 2,63 10,95 C18»10C1N305 70 56,53 2,71 10,71 4-CH30CgH4 379,33 234 až 235 60,20 3,46 11,09 C19H13N3°6 65 60,29 3,50 10,88 Hd 273,20 206 až 208 t.t. 206-7 °C / / C12H7N3°5 50 Y® 283,23 235 až t.t. 235 °C / / G14H9N3°4 64Physical constants 1- (5-nitro-2-furyl) -2- (5-X-2-furyl) -1,4,4-oxadiazolyl] ethene X Synthesis Molecular Weight T.t.c. You calculated / calculated # C% H% N 2-K02CfiH4 394.30 230 to 231 55.05 2.55 14.21 C18H10N4 ° 7 75 54.93 2.54 14.11 4-BrC6H4a 428.21 225 to 226 50.60 2.36 9.83 C18H10BrN3 ° 5 72 50.38 2.44 9.71 3-ClC6H4b 383.75 234 to 235 56.55 2.63 10.95 C18H10C1N3 ° 5 68 56.68 2, 71 10.63 2-C1C6h4 ° 383.75 212 to 213 .56.55 2.63 10.95 C18 »10C1N305 70 56.53 2.71 10.71 4-CH30CgH4 379.33 234 to 235 60.20 3 , 46 11.09 C19H13N3 ° 6 65 60.29 3.50 10.88 Hd 273.20 206 to 208 tt 206-7 ° C (C 12 H 7 N 3 O 5 50 Y® 283.23 235 to m.p. 235 ° C / / G 14 H 9 N 3 ° 4 64

Claims (1)

202 037 8 * Br vypoč./stan. 18,67/18,75; b % Cl 9,26/9,23; 0 % Cl 9,26/9,17; d sa krystalizovalo z etanolu a vietky áaliie syntetizované látky sa krystalizovali z mo-nome ty létě ru e tylénglykolu; 8 Y je fenyl. PSE DME T VYNÁLEZU Spoaob přípravy l-/5-nitro-2-furyl/-2-/5-aubatituovanýeh-1,3,4-oxadiazolyl/eténovobecného vzorce o2» CH = CH kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-ehlór-fenyl/-2-furyl, 5-/2-ehlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, vyznaSený tým, Se na 5-eubstituované tetrazoly obecného vsorcaH202 037 8 * Br calculated / tent. 18.67 / 18.75; b% Cl 9.26 / 9.23; 0% Cl 9.26 / 9.17; d was crystallized from ethanol, and the allys of the synthesized substance were crystallized from mono-thylene glycol to summer; Y is phenyl. BACKGROUND OF THE INVENTION The preparation of 1- (5-nitro-2-furyl) -2- (5-aubatite-1,3,4-oxadiazolyl) ethene-general formula (2) CH = CH wherein R is phenyl, 2-furyl, 5 - (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-chlorophenyl) -2-furyl, 5- (2-fluorophenyl) -2-furyl and 5-furyl; - (4-methoxyphenyl) -2-furyl, characterized in that the 5-substituted tetrazoles of general formula kde R je fenyl, 2-furyl, 5-/2-nitrofenyl/-2-furyl, 5-/4-brómfenyl/-2-furyl, 5-/3-chlór-fenyl/-2-furyl, 5-/2-chlórfenyl/-2-furyl a 5-/4-metoxyfenyl/-2-furyl, sa poaobí s 3-/5-nitro-2-furyl/akryloylacetylanhydridom vsorca NO; CH=CH-CO-O-CO-CH3 v inertnom rozpúStadle, ako například bensénu, toluénu, ο-, η-, p-zylénu a mezitylénu,pri teplotách od 70 do 140 °C. Vytiskly Moravské tiskařské závody,provoz 12, Leninova 21, Olomouc Cena; 2,40 Kčswherein R is phenyl, 2-furyl, 5- (2-nitrophenyl) -2-furyl, 5- (4-bromophenyl) -2-furyl, 5- (3-chlorophenyl) -2-furyl, 5- [ 2-chlorophenyl / -2-furyl and 5- (4-methoxyphenyl) -2-furyl are treated with 3- (5-nitro-2-furyl / acryloylacetylanhydride) with NO; CH = CH-CO-O-CO-CH3 in an inert solvent such as bensene, toluene, ο-, η-, p -ylene and mesitylene, at temperatures from 70 to 140 ° C. Printed by Moravian Printing Works, Operation 12, Leninova 21, Olomouc Price; 2,40 Kčs
CS575479A 1979-08-24 1979-08-24 Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes CS202637B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS575479A CS202637B1 (en) 1979-08-24 1979-08-24 Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS575479A CS202637B1 (en) 1979-08-24 1979-08-24 Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes

Publications (1)

Publication Number Publication Date
CS202637B1 true CS202637B1 (en) 1981-01-30

Family

ID=5403036

Family Applications (1)

Application Number Title Priority Date Filing Date
CS575479A CS202637B1 (en) 1979-08-24 1979-08-24 Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes

Country Status (1)

Country Link
CS (1) CS202637B1 (en)

Similar Documents

Publication Publication Date Title
ES2791315T3 (en) Triazole agonists of the APJ receptor
EP3466955B1 (en) Method of preparing oxazolo[4,5-b]pyridine and thiazolo[4,5-b]pyridine derivatives as irak4 inhibitors for treating cancer
US4639523A (en) Aminoalkylphenoxy derivatives
CN102143962B (en) Compounds having antiviral properties
CA3075751A1 (en) Pyrazolopyrimidinone compounds and uses thereof
JP2008539185A (en) Pyrazole compounds as prostaglandin receptor ligands
SK49999A3 (en) Oxadiazole derivatives, process for their preparation and their use as medicaments
JP2021535207A (en) Thyroid hormone receptor beta agonist compound
KR20090005195A (en) Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
TW200300679A (en) Substituted dipheny1 heterocycles useful for treating HCV infection
JP2008539183A (en) Oxazole and thiazole compounds and their use in the treatment of PGE2-mediated disorders
EP3704107B1 (en) Multicyclic compounds as farnesoid x receptor modulators
JP2022544714A (en) Thyroid hormone receptor beta agonist compounds
PT99821A (en) Process for the preparation of novel benzoyl benzene and pharmaceutical compositions containing the same
BR112021007602A2 (en) 5-membered heteroaryl carboxamide compounds for hbv treatment
ES2391549T3 (en) Pyrimidodiazepinone derivative
EP4251625A1 (en) Tricyclic compounds
BR112021015963A2 (en) BICYCLIC COMPOUNDS SUBSTITUTED AS FARNESOID X RECEPTOR MODULATORS
Burch et al. Nitrofuryl Heterocycles. III. 1 3-Alkyl-5-(5-nitro-2-furyl)-1, 2, 4-triazoles and Intermediates
JPH03170481A (en) Substituted pyrimidebenzimidazole derivative
JP2008539181A (en) Furan compounds useful as EP1 receptor antagonists
JP2022534501A (en) tricyclic compound
JP2022535794A (en) Bicyclic compounds and their use as RIP-1 kinase inhibitors
CS202637B1 (en) Process for preparing 1-/5-nitro-2furyl/-2-/5-substituted 1,3,4,-oxadiazolyl/ethenes
CN117479934A (en) HIPK2 inhibitors for the treatment of renal fibrosis